February 16th 2025
Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
February 13th 2025
New Study Further Illuminates PARP1 Expression in ALL, AML, CML With BCR::ABL1 p190+
October 3rd 2024Researchers investigate the expression of PARP1 in leukemias with BCR::ABL1 p190+ translocation, finding differential expression in ALL, AML, and CML but no significant correlation with clinical parameters.
Read More
Addressing Trauma: A Vital Component in Behavioral Health
October 3rd 2024This interview accompanies the final podcast in our National Recovery Month series with Lyndra Bills, MD, senior medical director, and Shari Hutchison, MS, director of program evaluation and outcomes, both with Community Care Behavioral Health Organization, part of the UPMC Insurance Services Division.
Watch
Achieving the Goals of Value-Based Care for Multiple Sclerosis
October 1st 2024Value-based agreements come with risks and benefits, but a health system’s existing facilities and initiatives can help support the goals associated with them, JT Lew, PharmD, MBA, a managed care pharmacist at MultiCare Health System, explained.
Read More
How Technological Innovations Could Improve CVD Risk Factor Management
September 26th 2024Benjamin Scirica, MD, MPH, director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division, discussed the importance of team-based care and gaps in technology to manage patients at risk of cardiovascular disease (CVD).
Watch
Greater Awareness, Community Empowerment Needed in CVD Prevention Efforts
September 25th 2024Laurence Sperling, MD, executive director of the Million Hearts initiative at the CDC and CMS, shared insight into population health strategies to address cardiovascular disease (CVD) prevention in at-risk populations.
Watch
Korean Study Finds DOAC Use “Seems Effective” in Patients With MPNs
September 25th 2024A study based on a decade's worth of Korean insurance data found that use of direct oral anticoagulants (DOACs) to address atrial fibrillation and venous thromboembolism in patients with myeloproliferative neoplasms (MPNs) is effective, with acceptable bleeding risk.
Read More
A Silent Risk: The Critical Role of Awareness and Early Detection in Familial Hypercholesterolemia
September 24th 2024September 24 celebrates Familial Hypercholesterolemia Awareness Day, which recognizes the importance of screening measures, education, and advocacy in a lesser-known, underdiagnosed cardiovascular condition.
Read More
New Research Unearths Evidence of Global Metabolic Disruption in Patients With SMA
September 21st 2024A recent analysis investigated the state of metabolic disruption experienced by patients with spinal muscular atrophy (SMA), adding to the literature on nutritional and metabolic complications linked to SMA.
Read More
We Need to Act Earlier to Address the Silent Crisis of Kidney Disease, Inadequate Federal Support
September 20th 2024The author discusses a program to prevent kidney decline and progression to dialysis by offering education, support services, and help navigating the health care system to those most at risk.
Read More